IP Library Granted Patent US 11,041,869
Granted Patent B2
US 11,041,869 · App. 14/906,589 · Granted Jun 22, 2021

Method and reagent for quantifying cholesterol in high density lipoprotein 3

Inventors: Noriyuki Sato (Gosen, JP); Yasuki Itoh (Gosen, JP)
Assignee: DENKA COMPANY LIMITED
G01N33/92C07C43/20C07C43/215C12Q1/60G01N2405/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,041,869
App. No.
14/906,589
Granted
Jun 22, 2021
Kind
B2
Abstract

Disclosed are a method and a reagent for quantifying HDL3 in a test sample without requiring laborious operations. The method for quantifying cholesterol in high-density lipoprotein 3 comprises reacting a test sample with one or more surfactants which react specifically with high-density lipoprotein 3, and quantifying cholesterol. When one surfactant is used, the surfactant is one selected from the group consisting of polyoxyethylene polycyclic phenyl ethers having an HLB of 12.5 to 15. When two or more surfactants are used, at least one of the surfactants is at least one selected from the group consisting of polyoxyethylene polycyclic phenyl ethers, and the two or more surfactants are combined so as to provide the total HLB of 12.5 to 15 of the combined surfactants.

Claims (11)

1. A method for quantifying cholesterol in high-density lipoprotein 3, said method comprising:

reacting a test sample with two or more surfactants which react specifically with high-density lipoprotein 3; and

quantifying cholesterol;

wherein said two or more surfactants are ones selected from the group consisting of polyoxyethylene polycyclic phenyl ethers;

wherein a total concentration of said surfactants is 0.25 to 1.25 w/v % in terms of the final concentrations;

wherein the two or more surfactants provide a reaction ratio of high-density lipoprotein 3 to high-density lipoprotein 2 (HDL3/HDL2) of 4.6 to 10.6; and

wherein the two or more surfactants are combined so as to provide the total hydrophilic-lipophilic balance (HLB) of 13.7 to 14.0 of the combined surfactants.

2. The method according to claim 1 , wherein said polyoxyethylene polycyclic phenyl ethers are polyoxyethylene styrenated phenylethers.

3. The method according to claim 2 , wherein said polyoxyethylene styrenated phenylethers are polyoxyethylene distyrenated phenylethers.

4. The method according to claim 1 , wherein the total concentration of said surfactants is 0.5 to 1.25 w/v % in terms of the final concentrations.

5. The method according to claim 1 , wherein the total concentration of said surfactants is 0.25 to 1.0 w/v % in terms of the final concentrations.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBERS 10007286 AND 10415007 PREVIOUSLY RECORDED AT REEL: 054513 FRAME: 0142. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Dec 14, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 055437/0045 →
MERGER Recorded Nov 24, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 054513/0142 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2016
From: SATO, NORIYUKI; ITOH, YASUKI
To: DENKA SEIKEN CO., LTD.
Reel/Frame 037547/0684 →
Priority Claims (1)
JP JP2013-153294 · Jul 24, 2013 · national
Continuity (1)
Related Publication 20160161512A1 · Jun 9, 2016